BRIEF-FDA grants priority review for Bayer's radium-223 dichloride

FRANKFURT Wed Feb 13, 2013 1:05am EST

Related Topics

FRANKFURT Feb 13 (Reuters) - Bayer AG : * Says FDA granted priority review for radium-223 dichloride (radium-223)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.